Open AccessThe possibility of perindopril in angioprotective in patients with metabolic syndrome after combination therapy with a thiazide diuretic
Author(s) -
С. В. Недогода,
В. О. Смирнова,
V Yu Khripaeva,
Р. В. Палашкин,
A. A. Ledyaeva,
Е В Чумачок,
A. S. Salasyuk
Publication year - 2016
Publication title -
sistemnye gipertenzii
Language(s) - English
Resource type - Journals
eISSN - 2542-2189
pISSN - 2075-082X
DOI - 10.26442/sg29121
Subject(s) - hydrochlorothiazide , perindopril , metabolic syndrome , medicine , thiazide , diuretic , combination therapy , losartan , cardiology , endocrinology , blood pressure , renin–angiotensin system , obesity
Aim. To assess the possibility of monotherapy with perindopril after transferring from combination therapy with losartan and hydrochlorothiazide with respect to correction of the anthropometric, metabolic parameters, premature vascular aging and vascular elasticity in patients with metabolic syndrome. Material and methods. Held open prospective controlled study of 50 patients with metabolic syndrome (IDF, 2005), which reached BP